Ekso Bionics (EKSO) Tops Q3 EPS by 1c

Ekso Bionics (NASDAQ: EKSO) reported Q3 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $5.55 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• JPMorgan Reiterates Underweight Rating on Hapag-Lloyd AG (HLAG:GR) (HLAGF)
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight